Methyprylon

Methyprylon

SCHEMBL623597

CCC1(CC)C(=O)NC[C@@H](C)C1=O.O=C(O)/C=C/C(=O)O

nearest known ligand 0.32

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQ

The experimentally established mechanism targets of Methyprylon. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.32
CYP19A1 P11511 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyprylon SCHEMBL1326559 1.00 LMNA (0.32) LMNACYP19A1
Methyprylon SCHEMBL7683591 0.89 LMNA (0.34) LMNACYP19A1
Methyprylon SCHEMBL155838 0.87 LMNA (0.40) LMNACYP19A1
Methyprylon SCHEMBL155839 0.87 LMNA (0.40) LMNACYP19A1
Methyprylon SCHEMBL8663851 0.84 LMNA (0.33) LMNACYP19A1
Methyprylon SCHEMBL10792726 0.84 LMNA (0.38) LMNACYP19A1
Methyprylon SCHEMBL9014931 0.83 LMNA (0.34) LMNACYP19A1
Methyprylon SCHEMBL6695974 0.83 LMNA (0.34) LMNACYP19A1
Methyprylon SCHEMBL8665659 0.69
Fumaric Acid SCHEMBL29291370 0.60 TSHR (0.64) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2011514671-A 2011-05-06 JP claimed
US-20110046268-A1 Self-Filleting Die Attach Paste WANG MINGHAI 2011-02-24 US claimed
EP-2250227-A1 SELF-FILLETING DIE ATTACH PASTE Henkel AG & Co. KGaA (DE) 2010-11-17 EP claimed
WO-2009105911-A1 SELF-FILLETING DIE ATTACH PASTE NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING COPORATION (US) 2009-09-03 WO claimed
US-11891537-B2 Triphenylphosphine-containing coatings with enhanced adhesion to unprimed surfaces SHEBOYGAN PAINT COMPANY (US) 2024-02-06 US disclosed
US-20220325110-A1 TRIPHENYLPHOSPHINE-CONTAINING COATINGS WITH ENHANCED ADHESION TO UNPRIMED SURFACES SHEBOYGAN PAINT COMPANY 2022-10-13 US disclosed
WO-2022212457-A1 TRIPHENYLPHOSPHINE-CONTAINING COATINGS WITH ENHANCED ADHESION TO UNPRIMED SURFACES SHEBOYGAN PAINT COMPANY (US) 2022-10-06 WO disclosed
US-9200009-B2 Polycyclic pyridone derivative having integrase inhibitory activity SHIONOGI & CO., LTD. (JP) 2015-12-01 US disclosed
US-20140256937-A1 POLYCYCLIC PYRIDONE DERIVATIVE HAVING INTEGRASE INHIBITORY ACTIVITY SHIONOGI & CO., LTD. (JP) 2014-09-11 US disclosed
US-8716368-B2 Unsaturated polyester resin or vinyl ester resin composition DSM IP ASSETS B.V. (NL) 2014-05-06 US disclosed
US-8211967-B2 Composite repair resins containing minimal hazardous air pollutants and volatile organic compound DREXEL UNIVERSITY (US) 2012-07-03 US disclosed
US-20120041124-A1 COMPOSITE REPAIR RESINS CONTAINING MINIMAL HAZARDOUS AIR POLLUTANTS AND VOLATILE ORGANIC COMPOUND DREXEL UNIVERSITY (US) 2012-02-16 US disclosed
US-4411899-A Substituted derivatives of amino alkane diols as gastric secretion inhibitors MERCK & CO., INC. (US) 1983-10-25 US disclosed
EP-0082376-A2 Substituted derivatives of amino alkane diols as gastric secretion inhibitors MERCK & CO. INC. (US) 1983-06-29 EP disclosed
EP-0059903-A1 Diaminooxadiazoles, their use as gastric secretion inhibitors, and process for their preparation MERCK & CO. INC. (US) 1982-09-15 EP disclosed
EP-0040696-A2 Aminothiadiazoles as gastric secretion inhibitors MERCK & CO. INC. (US) 1981-12-02 EP disclosed
US-4293616-A CELLULOSE, MASONRY, CURING GENERAL ELECTRIC COMPANY (US) 1981-10-06 US disclosed
US-4247445-A ROOM-TEMPERATURE VULCANIZABLE SILICONE RUBBER COMPRISING A POLYSILOXANE, CALCIUM CARBONATE, ACYLOXYSILANE, AND CATALYST GENERAL ELECTRIC COMPANY (US) 1981-01-27 US disclosed
US-4101602-A COATINGS THE GENERAL TIRE & RUBBER COMPANY (US) 1978-07-18 US disclosed
US-4061845-A PROTECTIVE OR DECORATIVE COATINGS FOR BONDERIZED STEEL THE GENERAL TIRE & RUBBER COMPANY (US) 1977-12-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140256937-A1 POLYCYCLIC PYRIDONE DERIVATIVE HAVING INTEGRASE INHIBITORY ACTIVITY TYMP, CDK6, IMPA1 LMNA 1344/4885CYP19A1 1072/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.